๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-04-08

Radioembolization Versus External Radiation Therapy (NCT07530172)

๐ŸŸข Recruiting Phase2 ๐Ÿ“‹ Clinical Research Protocol Sponsor: Henry Ford Health System

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The proposed study is a single site, prospective, randomized phase 2 study to evaluate the efficacy and tolerability transarterial radioembolization (TARE) versus stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma. The SBRT arm of the trial will involve standard SBRT delivered over 3-5 fractions as tolerated with dose/total therapy adjusted as needed for safety. The TARE arm of the trial will involve a planning arteriogram followed by selective transarterial delivery of Yttrium-90 into the segmental (โ‰ค2) artery supplying the tumor. Administered activity will be an amount prescribed to deliver a dose โ‰ฅ200 Gy to the perfused tissue. The primary endpoint is the rate of re-treatment of the index lesion over 12 months.

Who can join: Review the eligibility criteria below.

Location: Henry Ford Health System โ€” Detroit, Michigan

Age range: 18 Years

๐Ÿงช Interventions in This Study

  • Transarterial Radioembolization (RADIATION)
  • Stereotactic Body Radiation Therapy (SBRT) (RADIATION)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Henry Ford Health System โ€” Detroit, Michigan

๐Ÿ“ž Contact the Study Coordinator

Phone: (313) 556-8422

Email: mgilber6@hfhs.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—